GORD Flashcards
Presentation of GORD
Heartburn Acid regurgitation Retrosternal or epigastric pain Bloating Nocturnal cough Hoarse voice
When to refer for endoscopy as 2WW
They key red flag features indicating referral are:
Dysphagia (difficulty swallowing) at any age gets a two week wait referral
Aged over 55 with weight loss and any of these:
- Upper abdominal pain
- Dyspepsia
- Reflux
Management of GORD
Lifestyle advice:
- Reduce caffeine
- Reduce alcohol
- Weight loss
- Avoid smoking
- Smaller lighter meals
- Stay upright after meals
- Gaviscon/Rennie as needed
PPIs - first line
- Full dose PPI for 4-8w (if there is a response but symptoms then recur continue on lowest possible dose PPI)
- Second line is Ranitidine (H2 receptor antagonist) (if no response to PPI)
How do PPIs and H2 receptor antagonists work?
PPIs - reduce acid secretion in the stomach
H2 receptor antagonist (antihistamine) - reduces stomach acid
Investigations to do in GORD
Offer an H. Pylori test:
- CLO test during endoscopy
- Urea breath test
- Stool antigen test
Need 2 weeks without PPI use before H. Pylori test for an accurate result
Potential surgical management in GORD
Laparoscopic fundoplication - fundus of stomach tied around lower oesophageal sphincter to narrow it
How is H. Pylori treated?
Triple therapy - PPI plus 2 antibiotics (e.g. amoxicillin and clarithromycin) for 7 days.
What are potential complications of GORD?
Barrett’s oesophagus
Oesophagitis
Stricture formation
Ulceration
What is Barrett’s oesophagus?
Metaplasia from squamous to a columnar epithelium in the oesophagus
It is a pre-malignant condition and a RF for developing adenocarcinoma of the oesophagus
How is Barrett’s oesophagus treated?
Regular endoscopy to monitor for any dysplastic chance towards adenocarcinoma
PPIs
Ablation treatment during endoscopy using photodynamic therapy, laser therapy or cryotherapy is used to destroy the epithelium so that it is replaced with normal cells. This is not recommended in patients with no dysplasia but has a role in low and high grade dysplasia in preventing progression to cancer.